Abstract:Ezrin is known to regulate cellular survival, adhesion, migration, and invasion and has been identified as 1 of the key components of tumor progression and metastasis. The purpose of this study was to evaluate the clinicopathologic and prognostic significance of ezrin expression in non-small-cell lung cancer (NSCLC).We investigated the expression pattern of ezrin immunohistochemically in 89 paraffin samples of NSCLC between January 1998 and December 2006 and conducted survival analyses. In addition, 73 frozen specimens (including tumorous and precancerous tissues) of NSCLC and 28 frozen specimens of benign pneumonic diseases collected between January 2009 and December 2009 were analyzed by Western blot and reverse transcriptase-polymerase chain reaction (RT-PCR).In 89 paraffin samples, ezrin was expressed in 40 cases, either in the cytoplasm or on the membrane. Ezrin-positive expression was significantly associated with increased tumor stage and lymph node (LN) metastasis. The positive rate of cytoplasm expression was significantly associated with LN metastasis. Importantly, ezrin-positive expression independently predicted inferior overall survival (OS) and disease-free survival (DFS). In 73 frozen specimens of NSCLC and 28 frozen specimens of benign pneumonic diseases, the ezrin mRNA, protein, and phospho-ezrin protein expressions in tumorous tissues were higher than they were in precancerous tissues and benign pneumonic tissues.These results suggested that high-level ezrin expression contributed to NSCLC progression and that phosphorylation and subcellular translocation of ezrin might be the important mechanisms. Ezrin might be a potential prognostic marker of progression in NSCLC.

Construction of Eukaryotic Expression Vector of Short Hairpin RNA for Ezrin

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

[Construction of Shrna Expression Vector Silencing Kir6.2 Gene and to Study Its Influence on the Proliferation and Invasion of HepG2 Cells].

RNAi-mediated Blocking of Ezrin Reduces Migration of Ectopic Endometrial Cells in Endometriosis

Construction and identification of vector against Kir6.2 gene expression in hepatoma cells by short interfering RNAs

Construction of RhoC-siRNA expression vector and its role in invasion and metastasis ability of hepatoma carcinoma cell

Construction and Assessment of Short-Hairpin Rna Eukaryotic Expression Vector Targeting Tgf-Beta 1 Labeled by Gfp

Construction and Identification of Ph1-Ephb4-shrna Expression Vector

Construction of shRNA Expressing Plasmid Vector Inducing RNAi for EGFR Gene

Sirnas Target Sites Selection of Ezrin and the Influence of RNA Interference on Ezrin Expression and Biological Characters of Osteosarcoma Cells

Construction of COL1A1 Short Hairpin RNA Vector and Its Effect on Cell Proliferation and Migration of Gastric Cancer Cells

Construction and in Vitro Identification of CXCR4 Target Plasmid Vector of Short Hairpin RNA

Expression and clinical significance of ezrin in non--small-cell lung cancer.

Construction of Shrna Expression Vector Targeting the HSP27 Gene and Their Expression in Human Gemcitabine-Resistant Pancreatic Cell Line

Construction of shRNA expression vector targeting AATF and establishment of stably transfected U937 cells]

Construction of MicroRNA-22 Eukaryotic Expression Vector and Stable Expression in Ovarian Cancer Cell Line SKOV-3

Construction of FAK shRNA vector driven by the tumor-specific survivin promoter

Study on Inhibiting Expression of IGF1R in Hepatocellular Carcinoma Cells by Constructing Shrna Eukaryotic Expression Vectors

Interfering CXCR4 Expression Inhibits Proliferation,adhesion and Migration of Breast Cancer MDA-MB-231 Cells

Construction and Expression of Silence Expression Vector for Beta-Estrogen Receptor

Construction of shRNA lentivirus vector targeting rat Eap1 gene and Eap1 effects on Kiss1 gene at cellular level